Sökning: "lipid-lowering drugs"
Visar resultat 6 - 10 av 26 avhandlingar innehållade orden lipid-lowering drugs.
6. Diabetes in primary care : quality of life, metabolic control, drugs and socioeconomic factors
Sammanfattning : Diabetes is one of the most common chronic diseases affecting the Swedish population, with a prevalence of 3-4%. Most diabetic patients receive their care in the primary health care service. LÄS MER
7. Aspects on coronary heart disease prevention in clinical practice
Sammanfattning : Prevention of first time disease or recurrence of coronary heart disease (CHD) is a major task for the health service. Guidelines regarding CHD prevention have been issued but studies have shown that treatment goals are inadequately met in clinical practice and there is urgent need for improved methods of implementation of guidelines. LÄS MER
8. Quality of care and quality of life in coronary artery disease
Sammanfattning : The aim was to study the efficacy in primary care of Case method learning (CML) in secondary prevention of patients with coronary artery disease (CAD). A further aim was to explore the structure of health related quality of life (HRQL) in these patients and its relations to chest pain and ill health. LÄS MER
9. CYP3A and lipids in health and disease : in females and males
Sammanfattning : Sex and gender differences in the pharmacokinetics-and dynamics of drugs, have been known for centuries. Women have been regarded as different - a 70 kg male has been the norm in medicine. LÄS MER
10. Impact of Risk Factors and Treatment in Coronary Heart Disease
Sammanfattning : Aims: The aim of the present study was to explore how risk factors and medication influence clinical presentation and mortality in coronary heart disease (CHD) and to explain how much of the decrease in CHD mortality in Sweden that could be attributed to medical and surgical treatments, and how much to changes in cardiovascular risk factors. Subjects and methods: We included 781 consecutive patients with a first acute myocardial infarction (AMI) during the period 1994 to 2002, to investigate trends in the use of lipid-lowering treatment, and changes in serum lipids. LÄS MER